English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse
  1. View item / 
  2. Item Summary

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Patent

Synthetic vaccines against Streptococcus pneumoniae type 1

MPS-Authors
/persons/resource/persons121849

Seeberger,  Peter H.
Peter H. Seeberger - Vaccine Development, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

/persons/resource/persons121719

Pereira,  Claney Lebev
Peter H. Seeberger - Vaccine Development, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

/persons/resource/persons121100

Chakkumkal,  Anish
Chakkumal Anish, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

/persons/resource/persons127929

Schumann,  Benjamin
Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

2156974.pdf
(Publisher version), 6MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Seeberger, P. H., Pereira, C. L., Chakkumkal, A., & Schumann, B.(2015). Synthetic vaccines against Streptococcus pneumoniae type 1.


Cite as: https://hdl.handle.net/11858/00-001M-0000-0027-5F65-2
Abstract
The present invention relates to the total synthesis of saccharide structures contained in the capsular polysaccharide
of Streptococcus pneumoniae type I, to glycoconjugates containing said saccharide structures obtained by total synthesis and to use
of such glycoconjugates and pharmaceutical compositions thereof in the immunization against diseases associated with bacteria containing
said saccharide structures in their capsular polysaccharide, and more specifically associated with Streptococcus pneumoniae.